USPTO Examiner HIRT ERIN E - Art Unit 1616

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
17257187URACIL COMPOUND AND USE THEREOFDecember 2020July 2023Allow3010NoNo
17256397SYNERGISTICALLY EFFECTIVE HERBICIDE COMPOSITION COMPRISING METOBROMURON AND CLOMAZONEDecember 2020June 2024Allow4230YesNo
17126274METHOD OF TREATING FIBROSISDecember 2020April 2024Allow4031YesNo
17123584AGRICULTURAL COMPOSITIONS AND METHODS OF USE THEREOFDecember 2020January 2024Abandon3721NoNo
17250208HERBICIDAL FORMULATIONS COMPRISING GLYPHOSATE AND COTE-BASED ADJUVANTSDecember 2020January 2024Allow3710YesNo
17113206MOLECULE HAVING PESTICIDAL UTILITY, AND COMPOSITIONS, AND PROCESSES, RELATED THERETODecember 2020March 2023Allow2720YesNo
17055512LUNG SURFACTANT-BASED ANTICANCER DRUGNovember 2020March 2024Abandon4010NoNo
17053348cis-p-Menthane-1,8-Di-secondary Amine Compounds as well as Their Preparation Methods and Application in Weed ControlNovember 2020August 2024Abandon4521NoNo
17063458ANTISEPTIC, ANTISEBORRHEIC AND EXFOLIATING COMPOSITION TO REMOVE OR PREVENT ACNEOctober 2020October 2022Abandon2410NoNo
17061134Preparation Method of Antibacterial Deodorizing Modified Fiber for Water PurificationOctober 2020May 2023Allow3210YesNo
17039232NOVEL-ALKYNYL-SUBSTITUTED 3-PHENYLPYRROLIDINE-2,4-DIONES AND USE THEREOF AS HERBICIDESSeptember 2020February 2024Abandon4010NoNo
17043969HERBICIDAL COMPOUNDSSeptember 2020August 2022Abandon2310NoNo
17042005FUNGICIDAL FERTILIZER COMPOSITION COMPRISING POTASSIUM PHOSPHITE AND GAMMA-POLY-GLUTAMIC ACIDSeptember 2020October 2024Abandon4820NoNo
16980603Herbicide FormulationSeptember 2020October 2024Abandon4920NoNo
16978922HERBICIDAL COMPOUNDSSeptember 2020March 2024Allow4210YesNo
16977071SEED, SOIL, AND PLANT TREATMENT COMPOSITIONS INCLUDING YEAST EXTRACTAugust 2020April 2022Abandon1910NoNo
16968555MALEIMIDE DERIVATIVES HAVING HERBICIDAL ACTIVITY, AGRONOMIC COMPOSITIONS OF THE MALEIMIDE DERIVATIVES, AND USES THEREOFAugust 2020December 2023Allow4011YesNo
16929420UNSATURATED FATTY ALCOHOL DERIVATIVES FROM NATURAL OIL METATHESISJuly 2020May 2023Allow3420YesNo
16927355METHOD OF SUSPENDING WEED GROWTH IN SOILJuly 2020February 2024Abandon4310NoNo
16922799FRUITY ODORANTJuly 2020February 2022Allow1910YesNo
16955809FLUORALKENYL COMPOUNDS, PROCESS FOR PREPARATION AND USE THEREOFJune 2020October 2022Abandon2811NoNo
16955554SUBSTITUTED THIOPHENYL URACILS, SALTS THEREOF AND THE USE THEREOF AS HERBICIDAL AGENTSJune 2020July 2022Allow2531NoNo
16900140PRAMIPEXOLE TRANSDERMAL DELIVERY SYSTEM AND USES THEREOFJune 2020December 2021Allow1820YesNo
16875855DPI FORMULATION CONTAINING SULFOALKYL ETHER CYCLODEXTRINMay 2020February 2022Allow2120YesNo
16764157PROCESS FOR THE PREPARATION OF ALKOXYLATES COMPOSITIONSMay 2020September 2023Abandon4021NoNo
16842480PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOFApril 2020November 2021Allow1910YesNo
16754016Pesticidally Active Pyrrole DerivativesApril 2020March 2022Allow2310YesNo
16754050Pesticidally Active Pyrrole DerivativesApril 2020May 2022Allow2610YesNo
16649626Herbicidally Active Pyridyl-/Pyrimidyl-Pyrimidine DerivativesMarch 2020March 2024Abandon4831NoNo
16823523ELECTROLYTE PURGATIVEMarch 2020November 2023Abandon4421NoNo
16644349FUNGICIDE COMPOSITION AND METHOD FOR CONTROLLING DISEASE OF CROPMarch 2020January 2023Allow3430YesNo
16639723HERBICIDAL COMPOUNDSFebruary 2020November 2022Allow3310YesNo
16638884HERBICIDALLY ACTIVE 3-PHENYL-5-TRIFLUOROMETHYLISOXAZOLINE-5-CARBOXAMIDES OF CYCLOPENTYLCARBOXYLIC ACIDS AND ESTERSFebruary 2020April 2022Abandon2610NoNo
16638726LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONSFebruary 2020April 2024Allow5031YesNo
16636698USE OF A NON-IONIC SURFACTANT WHICH IS A POLYOL DERIVATIVE AS A PLANT GROWTH STIMULATING AGENT OR AS AN ADJUVANTFebruary 2020January 2024Abandon4741YesNo
16776950TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOFJanuary 2020March 2022Allow2620NoNo
16777049INHALED POWDER FORMULATIONSJanuary 2020March 2022Abandon2530NoNo
16776876TREATING TURFGRASS FOR FUNGAL DISEASEJanuary 2020February 2023Abandon3620NoNo
16631749SUBSTITUTED 5-(HET-)ARYLPYRAZOLAMIDES AND SALTS THEREOF AND THEIR USE AS HERBICIDAL ACTIVE SUBSTANCESJanuary 2020April 2021Abandon1510NoNo
16629698MIXTURES COMPRISING A HERBICIDE AND A NITRIFICATION INHIBITOR SUCH AS 2-(3,4-DIMETHYL-1H-PYRAZOL-1-YL)SUCCINIC ACID (DMPSA) OR 3,4-DIMETHYL PYRAZOLIUM GLOCOLATE (DMPG)January 2020September 2022Abandon3201NoNo
16725338WEED CONTROL AND FERTILIZERDecember 2019March 2022Allow2720YesNo
16625296PIPERONYLIC ACID DERIVATIVE AND PREPARATION AND APPLICATION THEREOFDecember 2019September 2023Allow4560YesNo
16622204HERBICIDALLY ACTIVE 3-PHENYLISOXAZOLINE-5-CARBOXAMIDES OF TETRAHYDRO- AND DIHYDROFURANCARBOXAMIDESDecember 2019November 2022Allow3520YesNo
16621303HERBICIDALLY ACTIVE 3-PHENYLISOXAZOLINE-5-CARBOXAMIDES OF TETRAHYDRO AND DIHYDROFURAN CARBOXYLIC ACIDS AND ESTERSDecember 2019November 2022Allow3520YesNo
16699676VANADIUM INSULIN-MIMETICS, METHODS OF PREPARATION, AND METHODS FOR TREATMENT OF DIABETESDecember 2019October 2020Allow1120YesNo
16616946MICRO STRUCTURE AND ANTIFOULING ACTIVE SUBSTANCE SYNERGISTIC ANTIFOULING MATERIAL AND PREPARATION METHOD THEREOFNovember 2019August 2021Allow2120YesNo
16615736SEED TREATMENT AND RELATED METHODS AND APPARATUSNovember 2019April 2023Abandon4131NoNo
16614870HERBICIDAL AMIDESNovember 2019January 2022Allow2611YesNo
16683380METHODS FOR CONTROLLING BEEHIVE PESTS WITH FORMIC ACID-CONTAINING POLYESTERS AND RELATED COMPOSITIONSNovember 2019April 2024Abandon5341NoNo
16678110AGROCHEMICAL CONCENTRATES COMPRISING ALKOXYLATED ADJUVANTSNovember 2019July 2021Abandon2120NoNo
16610182FUNGICIDAL MIXTURE COMPRISING SUBSTITUTED 3-PHENYL-5-(TRIFLUOROMETHYL)-1,2,4-OXADIAZOLESNovember 2019January 2024Abandon5150YesNo
16610111Use of an Acyclic Picolinamide Compound as a Fungicide for Control of Phytopathogenic Fungi in Row CropsNovember 2019July 2021Abandon2020NoNo
16610187Substituted 5-(haloalkyl)-5-hydroxy-isoxazoles for Combating Phytopathogenic FungiNovember 2019July 2023Abandon4531NoNo
166096242-(HET)ARYL-SUBSTITUTED FUSED HETEROCYCLE DERIVATIVES AS PESTICIDESOctober 2019August 2022Allow3421YesNo
16663914FUNGICIDAL COMBINATIONSOctober 2019October 2023Abandon4741YesNo
16608301SUBSTITUTED SUCCINIMIDE DERIVATIVES AS PESTICIDESOctober 2019May 2021Allow1910YesNo
16608593N-(4-PYRIDYL)NICOTINAMIDE COMPOUND OR SALT THEREOFOctober 2019December 2023Allow5031YesNo
16500541PYRIDINE COMPOUNDSOctober 2019June 2023Abandon4521NoNo
16499061FUNGICIDAL COMPOSITIONSSeptember 2019December 2023Allow5140YesNo
16496802PYRIDYL-FORMAMIDINES HAVING A FUNGICIDAL ACTIVITY, THEIR AGRONOMIC COMPOSITIONS AND USE THEREOFSeptember 2019November 2023Abandon5060YesNo
16576587LIPOSOMAL APPARATUS AND MANUFACTURING METHODSSeptember 2019March 2021Abandon1801NoNo
16495724HERBICIDAL MIXTURE, COMPOSITION AND METHODSeptember 2019October 2023Allow4930YesNo
16559799SYNERGISTIC EFFECT OF ISOXABEN AND CELLULOSIN AS A HERBICIDESeptember 2019July 2022Allow3431YesNo
16558496TAUROLIDINE TREATMENT FOR MYC-EXPRESSING TUMORS IN MAMMALIAN BODIESSeptember 2019December 2021Abandon2811NoNo
16554186NEUROBLASTOMA TREATMENT WITH TAUROLIDINE HYDROLYSIS PRODUCTSAugust 2019July 2022Allow3511YesNo
16554100METHODS AND COMPOSITIONS FOR TREATING NEUROBLASTOMA IN A JUVENILE MAMMALIAN BODYAugust 2019November 2021Abandon2720NoNo
16489081Synergetic Biocidal Compositions Comprising 5-Chlorine-2-Methylisothiazolin-3-OneAugust 2019September 2021Abandon2401NoNo
16518550POGOSTONE DERIVATIVES AND METHODS OF USING THE SAMEJuly 2019September 2022Abandon3801NoNo
16479376COSMETIC COMPOSITIONJuly 2019February 2024Abandon5560YesYes
16479099ISOXAZOLIN-5-ONE DERIVATIVE AND HERBICIDE CONTAINING SAME AS ACTIVE INGREDIENTJuly 2019May 2021Allow2210YesNo
16477604COPOLYMER CONTAINING CYCLIC NITROXIDE RADICAL AND TRIALKOXYSILYL IN SIDE CHAIN, AND USE THEREOFJuly 2019March 2024Allow5661YesNo
16460970PROTEIN COMPOSITIONS FOR PLANT TREATMENTJuly 2019May 2023Abandon4740NoYes
16460274COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING BACTERIAL INFECTIONSJuly 2019June 2022Abandon3520NoYes
16457814NSAID ADMINISTRATION AND RELATED COMPOSITIONS, METHODS AND SYSTEMSJune 2019February 2022Abandon3120NoNo
16472507SUBSTITUTED 1,2,4-THIADIAZOLYLPYRROLONES AND 1,2,4-THIADIAZOLYLHYDANTOINS AND SALTS THEREOF AND USE THEREOF AS HERBICIDESJune 2019October 2021Abandon2801NoNo
16471146SUBSTITUTED HETEROARYL PYRROLONES AND SALTS THEREOF AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCESJune 2019March 2022Abandon3320NoNo
16444670NEMATODE DETERRENT COMPOSITIONSJune 2019November 2021Abandon2911NoNo
16437342BACTERIAL SPORE COMPOSITIONS FOR INDUSTRIAL USESJune 2019February 2022Abandon3230NoNo
16466964PROCESS FOR PRODUCING A COSMETIC ARTICLEJune 2019December 2023Allow5560YesYes
16462837USE OF A DIFLUORO-(2-HYDROXYPROPYL)PYRIDINE COMPOUND AS A FUNGICIDE FOR CONTROL OF PHYTOPATHOGENIC FUNGI OF CORNMay 2019December 2020Abandon1910NoNo
16416382Molecule having pesticidal utility, and compositions, and processes, related theretoMay 2019September 2020Allow1610YesNo
16348896AQUEOUS DISPERSION OF POLYALKENE SUPRAMOLECULAR POLYMER AND ITS USE IN COSMETICSMay 2019December 2023Abandon5531YesNo
16406477DOUBLE SALT IONIC LIQUIDS OF HERBICIDESMay 2019August 2020Abandon1620YesNo
16347604CONTROLLED RELEASE TABLET BASED ON POLYVINYL ALCOHOL AND ITS MANUFACTURINGMay 2019April 2021Abandon2301NoNo
16395346HORMONAL CONTRACEPTION USING A VAGINAL RING WHICH RELEASES ESTRIOLApril 2019January 2022Abandon3220NoNo
16393454TRIAZOLE ACC INHIBITORS AND USES THEREOFApril 2019May 2020Allow1310YesNo
163414634-AMINO SUBSTITUTED PHENYLAMIDINE DERIVATIVES AND THEIR USE TO PROTECT CROPS BY FIGHTING UNDESIRED PHYTOPATHOGENIC MICOORGANISMSApril 2019February 2023Abandon4640YesNo
16340461Pesticidal MixturesApril 2019January 2021Abandon2110NoNo
16339996MONOSUBSTITUTED UREA DERIVATIVES AS A SELF-TANNING SUBSTANCEApril 2019September 2021Allow3040YesNo
16339764BARBITURIC ACID DERIVATIVES AS SELF-TANNING SUBSTANCESApril 2019November 2021Abandon3221NoNo
16371670ANTISEPTIC, ANTISEBORRHEIC AND EXFOLIATING COMPOSITION TO REMOVE OR PREVENT ACNEApril 2019June 2020Allow1410YesNo
16337606COMPOSITION COMPRISING A BIOACTIVE MOLECULEMarch 2019September 2023Allow5451YesNo
16331419WATER-SOLUBLE CONTROLLED RELEASE COMPOSITION AND METHODS FOR MAKING AND USING THE SAMEMarch 2019November 2022Abandon4521NoNo
16293165PERCUTANEOUS ANTI-MICROBIOTA FORMULATIONSMarch 2019June 2021Abandon2821NoNo
16282549FORCHLORFENURON MIXTURES AND USES THEREOFFebruary 2019March 2022Allow3740YesNo
16281700NOVEL ESTERIFIED CELLULOSE ETHERS OF HIGH MOLECULAR WEIGHT AND HOMOGENEITYFebruary 2019December 2021Abandon3420NoNo
16269334ANTIMICROBIAL COATING FORMING KINK RESISTANT FEATURE ON A VASCULAR ACCESS DEVICEFebruary 2019July 2021Allow2920YesNo
16323739AGROCHEMICAL GEL COMPOSITIONFebruary 2019February 2024Abandon6070NoNo
16239360PYRAZOLE ACC INHIBITORS AND USES THEREOFJanuary 2019October 2020Allow2220NoNo
16225504PHOTOCLEAVABLE DRUG CONJUGATESDecember 2018December 2021Abandon3621YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HIRT, ERIN E.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
32
Examiner Affirmed
26
(81.2%)
Examiner Reversed
6
(18.8%)
Reversal Percentile
30.9%
Lower than average

What This Means

With a 18.8% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
75
Allowed After Appeal Filing
12
(16.0%)
Not Allowed After Appeal Filing
63
(84.0%)
Filing Benefit Percentile
20.1%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 16.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner HIRT, ERIN E - Prosecution Strategy Guide

Executive Summary

Examiner HIRT, ERIN E works in Art Unit 1616 and has examined 580 patent applications in our dataset. With an allowance rate of 33.6%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 36 months.

Allowance Patterns

Examiner HIRT, ERIN E's allowance rate of 33.6% places them in the 6% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by HIRT, ERIN E receive 2.78 office actions before reaching final disposition. This places the examiner in the 77% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by HIRT, ERIN E is 36 months. This places the examiner in the 35% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +15.3% benefit to allowance rate for applications examined by HIRT, ERIN E. This interview benefit is in the 54% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 12.2% of applications are subsequently allowed. This success rate is in the 8% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 19.7% of cases where such amendments are filed. This entry rate is in the 25% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 35.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 35% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 40.7% of appeals filed. This is in the 9% percentile among all examiners. Of these withdrawals, 27.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 84.4% are granted (fully or in part). This grant rate is in the 86% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 0% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 0% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.